Most Read Articles
Roshini Claire Anthony, 17 Jul 2019

A combination of tocilizumab and methotrexate reduced disease activity at 2 years compared with methotrexate plus prednisone in patients with early rheumatoid arthritis (RA), an effect not demonstrated with tocilizumab monotherapy.

08 Jul 2017
Entecavir and lamivudine demonstrate comparable effects on the mortality rate of patients with chronic hepatitis B virus (HBV)-related acute exacerbation with or without acute-on-chronic liver failure (ACLF), reports a study. In patients with ACLF, however, entecavir delivers a more favourable long-term outcome and is associated with greater clinical improvements.
Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
05 Oct 2019
The combination of sofosbuvir and velpatasvir is safe and effective for the treatment of hepatitis C virus (HCV) in patients with end-stage renal disease (ESRD) undergoing haemodialysis, a study has shown.

Antibiotic use during pregnancy may up risk of childhood asthma

Pearl Toh
01 Jun 2018
Dr Kedir Turi

Frequent use of antibiotics during pregnancy is associated with an increased risk of childhood asthma, with the risk varies by timing and number of antibiotic courses used during pregnancy, according to a study presented at ATS 2018.

“Timing of antibiotic use appears to be important with early pregnancy use [being] associated with higher childhood asthma risk,” said Dr Kedir Turi of Vanderbilt University Medical Center in Nashville, Tennessee, US.

Although maternal antibiotic use across all trimesters was associated with an increased risk of childhood asthma, the researchers found that the later mothers started their first course of antibiotics during pregnancy, the lower the risk of their children developing asthma (173 days vs 41 days, adjusted odds ratio [OR], 0.80, 95 percent confidence interval [CI], 0.75–0.86). [ATS 2018, abstract A4194]

However, the association appears to be reversed after 200 days of gestational age, with later antibiotic use (from 200 days onwards) being positively associated with increased childhood asthma risk.

The risk of developing childhood asthma also rose with increasing number of maternal antibiotic courses used during pregnancy in a dose-dependent manner. Compared with children whose mothers did not use any antibiotics during pregnancy, those whose mothers used two courses of antibiotics were 30 percent more likely to develop asthma between age 4.5–6 years.  

In addition, maternal antibiotic use during the first trimester only or during more than one trimester was associated with an 11 percent (OR, 1.11, 95 percent CI, 1.03–1.19) and 13 percent (OR, 1.13, 95 percent CI, 1.03–1.24) increased risk of developing childhood asthma, respectively, after adjustment for the number of antibiotic courses and covariates.

There was no significant association between the types of antibiotics used (broad- vs narrow-spectrum) and risk of childhood asthma. Broad-spectrum antibiotics are more commonly prescribed (91 percent) during pregnancy.

The retrospective population-based cohort study involved 84,880 mother-child pairs enrolled in the Tennessee Medicaid Program. Healthy children (52 percent male) who were born to term with non-low birth weight were considered eligible. Childhood asthma was assessed at age 4.5–6 years. By age 6, 14 percent of the children had developed asthma. Sixty-six percent of the mothers had ≥1 antibiotic course during pregnancy.   

“The mechanisms through which antibiotics lead to increased asthma need to be understood to be able to develop effective prevention strategies,” said Turi.

According to Turi, some possible reasons which could explain the association between maternal antibiotic use and childhood asthma include: antibiotics may be an indicator of infection, a marker of genetic predisposition for asthma, and that antibiotic use during pregnancy may change the mother's and child's microbiome.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 17 Jul 2019

A combination of tocilizumab and methotrexate reduced disease activity at 2 years compared with methotrexate plus prednisone in patients with early rheumatoid arthritis (RA), an effect not demonstrated with tocilizumab monotherapy.

08 Jul 2017
Entecavir and lamivudine demonstrate comparable effects on the mortality rate of patients with chronic hepatitis B virus (HBV)-related acute exacerbation with or without acute-on-chronic liver failure (ACLF), reports a study. In patients with ACLF, however, entecavir delivers a more favourable long-term outcome and is associated with greater clinical improvements.
Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
05 Oct 2019
The combination of sofosbuvir and velpatasvir is safe and effective for the treatment of hepatitis C virus (HCV) in patients with end-stage renal disease (ESRD) undergoing haemodialysis, a study has shown.